← Back
$URGN All transactions

UroGen Pharma Ltd.

M

$ Value

Shares

10,000

Price

Filed

Jul 30

Insider

Name

Schoenberg Mark

Title

Chief Medical Officer

CIK

0001763581

Roles

Officer

Transaction Details

Transaction Date

2025-07-28

Code

M

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

163,378

Footnotes

Represents the settlement of performance stock units granted on January 31, 2024 that vested upon the achievement of a corporate milestone event. | Each performance stock unit represents a contingent right to receive one ordinary share of the Issuer. | Represents shares sold to satisfy withholding tax obligations upon the settlement of performance stock units.

Filing Info

Accession No.

0001437749-25-023961

Form Type

4

Issuer CIK

0001668243

Schoenberg Mark's History

Date Ticker Type Value
2026-02-03 URGN $36K
2026-02-03 URGN $36K
2026-02-03 URGN $73K
2026-01-31 URGN M
2026-01-31 URGN M
2026-01-31 URGN M
2026-01-31 URGN M $0
2026-01-31 URGN M $0
2026-01-31 URGN M $0
2026-01-31 URGN A $0

Other Insiders at URGN (90d)

Insider Bought Sold Last
Robinson James A. Jr. 2025-02-26
Degnan Chris
Chief Financial Officer
2026-01-31
Schoenberg Mark
Chief Medical Officer
$145K 2026-02-03
Barrett Elizabeth A.
Chief Executive Officer
2026-01-31
Smith Jason Drew
General Counsel
$147K 2026-02-03